Abstract Background Trastuzumab has revolutionized the way we treat early Her2Neu-positive breast cancer. as it significantly improves disease-free and overall survival. Little is known about the societal costs and benefits of treatment with trastuzumab in the adjuvant setting in Southeast Asia. Methods Societal costs (benefits) were estimated as the sum of direct and indirect costs m... https://www.missouriquiltcoes.shop/product-category/sewing-boxes/